Christopher van Hofwegen, MD
Sports Medicine · Bellingham, WANPI 1376751669
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 19 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 11 manufacturers, the largest accounting for just 22.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $323 and has fallen 55.1% since, to $145 in 2025.
Across 19 payments — averaging $39.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$173
- Si-bone, Inc.$134
- Summit Surgical Corp.$124
- Bioventus LLC$83
- Arthrex$55
- Avanos Medical$46
- plus $140 from 5 others
What the payments were for
- Food & beverage$756100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 3 | $173 |
| Si-bone, Inc. | 2 | $134 |
| Summit Surgical Corp. | 2 | $124 |
| Bioventus LLC | 3 | $83 |
| Arthrex | 1 | $55 |
| Avanos Medical | 2 | $46 |
| Medical Device Business Services, Inc. | 2 | $43 |
| Johnson & Johnson | 1 | $37 |
| Davol Inc. | 1 | $22 |
| BD | 1 | $22 |
| Zimmer Biomet | 1 | $17 |
How this compares
$756 in reported general payments places this provider in the 55th percentile of 132 sports medicine providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Meloxicam | 73 | $724 |
| Mupirocin | 19 | $132 |
| Ondansetron Hcl | 41 | $111 |
| Oxycodone Hcl | 12 | $76 |
Paid to pharmacies, not to this prescriber.
Other sports medicine in Bellingham
- Paul HaederBellingham$4K
- Justis StolzBellingham$743
- Geoffrey HiggsProsser$569K
- Nicholas KennedyYakima$112K
- Nicholas VaudreuilEverett$49K
- Adam PourchoSeattle$38K
- Christopher WahlIssaquah$37K
- Nicholas WilcoxMarysville$36K
- Mathew TaylorPullman$36K
- Brandon NudelmanBellevue$32K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.